摘要
从１９８９年首次进行人类基因标记、１９９０年首例患者接受基因治疗以来，到１９９８年５月１５日，共计２５５７名患者接受了基因治疗。由于目前一些基因标记临床计划，如将ＴＩＬ细胞转入ＮｅｏＲ基因标记后注射入人体，观察这些ＴＩＬ细胞的最终归宿和命运的研究计划...
出处
《生命的化学》
CAS
CSCD
1999年第1期11-12,共2页
Chemistry of Life
同被引文献27
-
1Aznavoorian S, Murphy AN, Stetler-Stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis [J]. Cancer, 1993,71 (5) :1368.
-
2Kiluchi A, Aoki Y, Sugaya S, et al. Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor[J].Human Gene Therapy, 1999,10(9):947.
-
3Barajas M, Mazzolini G, C, enove G, et al. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12 [ J]. Hepatology, 2001,33 ( 1 ) : 52.
-
4Greenblatt MS, Benett WP, Hollstein M, et al. Mutation in the p.53 tumor suppressor gene : Clue to cancer etiology and molecular pathogenesis[J]. Cancer Res, 1994,54(12) :4855.
-
5Anderson SC,Johnson DE,Harris MP, et al.p.53 gene therapy in a rat model of hepatocellular carinoma: Intra-artefial delivery of a recombinant adenovirus[ J]. Clin Cancer Res, 1998,4( 11 ) : 1649.
-
6Weiss B, Davidkova G, Zhou LW. Antisense RNA gene therapy for studying and modulating biological processes [J]. Cell Mol Life Sci,1999,55(3) :334.
-
7Kashani-Sabet M, Scanlon KJ. Application of ribozymes to cancer gene therapyl J]. Cancer Gene Ther, 1995,2(2) ;213.
-
8Morino F,Tokunaga T, Tsuchida T, et al. Hammerhead ribozyme specifically inhibits vascular endothelial growth factor gene expression in ahuman hepatocellular carcinoma cell line [J]. Inc J Oncol, 2000, 17(2) :495.
-
9Von Marschall Z, Cramer T, Hocker M, et al. Dual mechanism of vascular endothelial growth factor upreguhtion by hypoxia in human hepatocellular carcinoma[ J] . Gut, 2001,48( 1 ) : 87.
-
10Kang MA, Kim KY, Seol JY, et al. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor [ J]. J Gene Med,2000,2(2) :289.
-
1黄慧芬.人类基因治疗研究进展[J].生物学杂志,1998,15(6):4-5.
-
2姜传仓,范乐明.腺病毒载体及其在基因治疗研究中的应用[J].生物化学与生物物理进展,1996,23(1):8-12. 被引量：3
-
3赵书鹤,汤永红.骨髓间充质干细胞及其在缺血性脑血管病中的应用[J].国际脑血管病杂志,2007,15(8):595-598.
-
4徐人欢,周霞秋,金由辛.慢性乙型肝炎的基因治疗研究[J].生命的化学,2000,20(2):89-92.
-
5卢大儒,邱晓云,郑冰,邱信芳,薛京伦.基因治疗研究中有复制能力逆转录病毒的检测[J].病毒学报,1996,12(2):135-141. 被引量：2
-
6汤美雯.树突状细胞与肿瘤免疫治疗[J].亚太传统医药,2012,8(10):211-212. 被引量：1
-
7邱双健.腺病毒载体研究新进展[J].国外医学（分子生物学分册）,1996,18(4):149-152. 被引量：1
-
8邹龙,刘洪,马霖杰,陈晓,陈刚.非生物型人工肝的治疗新进展[J].中国普外基础与临床杂志,2017,24(5):634-637. 被引量：8
-
9童锴,谢宜军,王月刚,吴平生.人双突变型低氧诱导因子1α真核表达载体的构建及鉴定[J].广东医学,2006,27(11):1650-1652. 被引量：1
-
10秦合伟,李彦杰,任锟,张志鑫,李鸿章.脑功能磁共振成像在针刺脑效应研究中的应用进展[J].中医临床研究,2017,9(8):144-147. 被引量：6
